Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neogen Corporation - Common Stock (NQ:NEOG)

5.630 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neogen Corporation - Common Stock

< Previous 1 2 3 4 Next >
Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Which stocks are moving on Wednesday?
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Neogen's Earnings: A Preview
Via Benzinga
A Glimpse of Neogen's Earnings Potential
Via Benzinga
Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results
Via Benzinga
Exposures Fossil Fuels
Top movers in Wednesday's pre-market session
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns
Neogen Corporation reports lower-than-expected Q3 earnings, declines in revenue, and a CEO transition, lowering its full-year guidance for 2025. 
Via Benzinga
Neogen (NASDAQ:NEOG) Misses Q1 Revenue Estimates, Stock Drops
Life sciences company Neogen (NASDAQ:NEOG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.4% year on year to $221 million. The company’s full-year revenue guidance of $895... 
Via StockStory
Neogen® Announces CEO Transition
From Neogen Corporation
Via Business Wire
Neogen Announces Third-Quarter 2025 Results
From Neogen Corporation
Via Business Wire
Earnings Scheduled For April 9, 2025
Via Benzinga
Neogen (NEOG) To Report Earnings Tomorrow: Here Is What To Expect
Life sciences company Neogen (NASDAQ:NEOG) will be reporting earnings tomorrow before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility
From Neogen Corporation
Via Business Wire
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. 
Via StockStory
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers. 
Via StockStory
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,... 
Via StockStory
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
Neogen (NEOG): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best... 
Via StockStory
Neogen (NASDAQ:NEOG) Posts Better-Than-Expected Sales In Q4
Life sciences company Neogen (NASDAQ:NEOG) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $231.3 million. Its non-GAAP profit of $0.11 per share was in line... 
Via StockStory
Earnings Scheduled For January 10, 2025
Via Benzinga
Inflation Slows Small Cap Rally, But SMCP ETF Offers Strategic Entry Point
Via Benzinga
Topics ETFs Economy
Exposures Interest Rates
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Insiders Buying Rocket Companies And 2 Other Stocks
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.